73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc
Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

byBrigham and Women’s HospitalGlobal characterization of the melanoma samples and their expression of CEACAM1. Credit:Communications Medicine(2024). DOI: 10.1038/s43856-024-00525-8Yu

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

byBrigham and Women’s HospitalGlobal characterization of the melanoma samples and their expression of CEACAM1. Credit:Communications Medicine(2024). DOI: 10.1038/s43856-024-00525-8Yu
Novel approach to study hypoxia enables identification of a marker for ovarian cancers

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795
Immune landscape and response to oncolytic virus-based immunotherapy

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of
Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura
Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C
Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca
New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D
AI tool 'DeepHRD' accelerates cancer treatment decisions

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge
Drug bypasses suppressive immune cells to unleash immunotherapy

Drug bypasses suppressive immune cells to unleash immunotherapy

by Marta Wegorzewska,Washington University School of MedicineImmunobiologists Robert Schreiber, Ph.D., (left) and Hussein Sultan, Ph.D., of Washington University School of Medicine in St. Louis,

Drug bypasses suppressive immune cells to unleash immunotherapy

by Marta Wegorzewska,Washington University School of MedicineImmunobiologists Robert Schreiber, Ph.D., (left) and Hussein Sultan, Ph.D., of Washington University School of Medicine in St. Louis,
Advancing towards a novel, highly accurate method for cervical cancer screening

Advancing towards a novel, highly accurate method for cervical cancer screening

byFujita Health UniversityAfter a preliminary screening round, researchers identified a set of microRNAs (miRNAs) and cytokines that are abnormally expressed in serum and mucus samples in cases

Advancing towards a novel, highly accurate method for cervical cancer screening

byFujita Health UniversityAfter a preliminary screening round, researchers identified a set of microRNAs (miRNAs) and cytokines that are abnormally expressed in serum and mucus samples in cases
Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di